At embryonic day 16.5 (E16.5), there were no pathological differences compared to control littermates, aside from transgene expression.
There were no pathological atypical features.
Although the exact reasons for this discrepancy are unclear, pathological differences observed between SOD1H46R and SOD1G93A mice might be related.
For example, whereas there are clear pathological differences between CTE and AD, understanding and differentiating the clinical symptoms, particularly in older adults, remains a significant challenge [ 78].
There were no morphological and pathological differences between xenografts formed by SK-ES1-DEST#1 and -DKK1#1 cells.
Apart from the tumor size and pathologic stage, there were no significant differences in pathological characteristics (including tumor location, histological subtypes, and Fuhrman grade) between the RN and PN groups (Table 2).
Using chi-square analysis there were no differences in pathological and biological characteristics between the two groups.
There were no differences in pathological type, histological grade, or estrogen receptor expression between focal type and diffuse type tumors (Table 1).
For tumor extent, there were no significant differences between pathological size and measured size using mammography, ultrasound, CT, or MRI with and without CAD (P > 0.05).
There were no significant differences in pathological findings when the groups were divided in 4 groups: patient-detected younger age (≤60 years), patient-detected elderly age (>60 years), physician-detected younger age (≤60 years), and physician-detected elderly age (>60 years).
